문성환

문성환 is a declared insider of 압타바이오, with filings sourced from DART (FSS). We count 6 filings; the first trade dates from 25 August 2021 and the latest from 28 April 2023.

On the market, this insider has only ever bought: 5 purchases, €704k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2023 to date brings 5 purchases and no sales.

Half of the purchases are above €115k and half below. 5 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 8 May 2023: an open-market purchase of €102k, in 압타바이오. Typically, a trade is published a median of 3 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.